Viewing Study NCT01189968


Ignite Creation Date: 2025-12-24 @ 5:34 PM
Ignite Modification Date: 2025-12-30 @ 1:44 AM
Study NCT ID: NCT01189968
Status: COMPLETED
Last Update Posted: 2020-09-09
First Post: 2010-08-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung Cancer
Sponsor: OncoMed Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module